Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-11-230748
Filing Date
2011-08-24
Accepted
2011-08-24 13:24:02
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q d10qa.htm 10-Q/A 24957
  Complete submission text file 0001193125-11-230748.txt   1968158

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT imuc-20110630.xml EX-101.INS 315330
3 XBRL TAXONOMY EXTENSION SCHEMA imuc-20110630.xsd EX-101.SCH 19426
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imuc-20110630_cal.xml EX-101.CAL 27572
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imuc-20110630_def.xml EX-101.DEF 32525
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE imuc-20110630_lab.xml EX-101.LAB 147058
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imuc-20110630_pre.xml EX-101.PRE 99742
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 033-17264-NY | Film No.: 111053512
SIC: 2834 Pharmaceutical Preparations